# TOBRAMYCIN AND DEXAMETHASONE
> **ANDA212715** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2022-02-11
## Drug
- **FDA Application Number:** ANDA212715
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOBRAMYCIN AND DEXAMETHASONE
- **Generic name:** TOBRAMYCIN AND DEXAMETHASONE
- **Active ingredients:** DEXAMETHASONE; TOBRAMYCIN
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** PADAGIS US
- **Manufacturer:** Padagis US LLC
- **First approval:** 2022-02-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212715)
---
*AI Analytics · CC0 1.0*